
|Articles|June 29, 2017
Santhera Selects Veeva Systems for Product Launch
Advertisement
Santhera Pharmaceuticals, rare disease pharmaceutical company, has selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The platform will be used to help Santhera establish a consistent, global approach to commercialization as it offers up-to-date customer reference data for field teams to enable faster, tailored interactions with HCPs.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
4
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
5




